Skip to main content
Caplight Logo









NirogGyan

NirogGyan

Private
DelhiHealthcare & Life Scienceshttps://www.niroggyan.com/

Last Round

Seed

Jul 16, 2021

Momentum

Top 5%

of companies Caplight tracks

Company Overview

NirogGyan operates in Healthcare & Life Sciences and is based in Delhi. Its latest recorded funding round was a Seed round in July 2021.

NirogGyan is a health-tech company that provides a patient engagement SaaS platform featuring smart medical reports, health insights dashboards, and conversational AI for healthcare providers.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Healthcare Analytics, Vertical SaaS, API Management, NLP & Conversational AI

Business Model

B2B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

NirogGyan Comparables

Compare NirogGyan with similar companies based on industry and business-model similarity.

NirogGyan comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CrelioHealth
79%
Medicus AI
79%
Luminate Health
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

NirogGyan Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 16, 2021
GrantJul 1, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

NirogGyan Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors increased 34% MoM.

  • Aug 29, 2026

    Grew 27% QoQ from 11 to 14 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

NirogGyan Filings

Explore SEC and related filing metadata, where available.

NirogGyan filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about NirogGyan's valuation, stock price, and market status.

Is NirogGyan a public or private company?

NirogGyan is a private company.

What is the current stock price of NirogGyan?

NirogGyan is a private company, so its shares have no public market price. Caplight tracks NirogGyan's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is NirogGyan worth (valuation)?

Valuation information for NirogGyan is not publicly available.

Can I buy NirogGyan stock?

NirogGyan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was NirogGyan's last funding round?

NirogGyan's most recent funding round was Seed on July 16, 2021.

Who are the main investors in NirogGyan?

Key investors in NirogGyan include Pilani Innovation and Entrepreneurship Development Society, Ministry of Electronics and Information Technology.

Will NirogGyan IPO soon?

No public IPO plans have been announced for NirogGyan.

How can I track NirogGyan secondary market activity?

Caplight tracks bids, offers, and trades in NirogGyan's shares on secondary markets.

Firmographic Details

HeadquartersDelhi
Employee Range14
Year Founded2019
Last FundingJul 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?